There are currently no planned studies in our center.
A phase II study of abemaciclib in patients with brain metastases secondary to hormone receptor positive breast cancer and melanoma
CHECKMATE 848 CA209-848
A Randomized, Open-Label, Phase 2 Study of Nivolumab in Combination With Ipilimumab or Nivolumab Monotherapy in Participants With Advanced or Metastatic Solid Tumors of High Tumor Mutational Burden (TMB-H)
CREATE EORTC 90101
Cross-tumoral Phase 2 Clinical Trial Exploring Crizotinib (PF-02341066) in Patients With Advanced Tumors Induced by Causal Alterations of ALK and/or MET